Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering
The integration of artificial intelligence (AI) in biotech is not just enhancing the efficiency of processes but is also enabling the discovery of novel biological insights that were once beyond reach. As the industry seeks to meet the increasing demand for protein-based products across various sectors, including pharmaceuticals, agriculture, and food, the role of AI becomes increasingly important.
In this context, our conversation with Stef van Grieken, Co-founder and CEO of Cradle, provides a glimpse into how cutting-edge AI technologies and strategic collaborations are accelerating the pace of innovation in protein engineering.
Stef shares the intriguing story behind Cradle's partnership with Ginkgo Bioworks, highlighting their shared vision and the synergistic combination of Cradle’s generative AI software and Ginkgo's robust experimental capabilities.
This interview delves into the growing impact of AI on biotechnological processes, the challenges currently faced by R&D teams, and how Cradle's unique approach is contributing to the protein engineering landscape.
Topics: AI & Digital
